tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ridgetech Reports Stable Revenue Amid Strategic Transformation

Story Highlights
Ridgetech Reports Stable Revenue Amid Strategic Transformation

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from Ridgetech ( (RDGT) ) is now available.

On July 28, 2025, Ridgetech, Inc. announced its financial results for the fiscal year ending March 31, 2025. The company reported stable revenue of approximately $120 million despite significant transformations, including the divestiture of its retail pharmacy business and the acquisition of Ridgeline and its subsidiary, Allright. This strategic shift reflects Ridgetech’s focus on the wholesale pharmaceutical sector, aiming to leverage Allright’s growing online and offline distribution network. The company experienced a decrease in offline wholesale revenue but saw new contributions from its online platforms. Ridgetech’s net income improved significantly, reaching $10.20 million, compared to a net loss in the previous year. The company increased its investment in sales and marketing to support its strategic transformation.

Spark’s Take on RDGT Stock

According to Spark, TipRanks’ AI Analyst, RDGT is a Underperform.

China Jo-Jo Drugstores is currently facing significant financial challenges, with negative profitability, high leverage, and declining cash flows being the primary concerns. Technical indicators also suggest a bearish outlook, with the stock trading below key moving averages. The valuation is unattractive due to negative earnings and the absence of a dividend. Overall, the stock is rated low, reflecting the need for strategic improvements to address financial instability and restore investor confidence.

To see Spark’s full report on RDGT stock, click here.

More about Ridgetech

Ridgetech, Inc., formerly known as China Jo-Jo Drugstores, Inc., is a growing online and offline wholesale distributor of pharmaceutical and other healthcare products in China. The company actively trades on popular online distribution platforms nationwide and has its own online distribution platform, offering greater opportunities to distribute pharmaceutical products across the country.

Average Trading Volume: 31,283

Technical Sentiment Signal: Sell

Current Market Cap: $8.03M

For an in-depth examination of RDGT stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1